4//SEC Filing
DRISCOLL JOSEPH 4
Accession 0001104659-22-038232
CIK 0001711933other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 7:23 PM ET
Size
7.3 KB
Accession
0001104659-22-038232
Insider Transaction Report
Form 4
DRISCOLL JOSEPH
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-03-23+25,000→ 25,000 totalExercise: $11.88Exp: 2032-03-23→ Common Stock (25,000 underlying) - Award
Common Stock
2022-03-23+12,500→ 12,500 total
Footnotes (3)
- [F1]The restricted stock units shall vest in four (4) equal annual installments beginning on the first anniversary of the grant date and on each anniversary thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.
- [F3]The options shall vest as follows: twenty-five percent (25%) shall vest on the first anniversary of the grant date with the remainder vesting in 36 equal monthly installments beginning on April 23, 2023.
Documents
Issuer
Akoya Biosciences, Inc.
CIK 0001711933
Entity typeother
Related Parties
1- filerCIK 0001392297
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 7:23 PM ET
- Size
- 7.3 KB